Abstract:Cell Competition is a process by which neighboring cells compare their fitness. As a result, viable but suboptimal cells are selectively eliminated in the presence of fitter cells. In the early mammalian embryo, epiblast pluripotent cells undergo extensive Cell Competition, which prevents suboptimal cells from contributing to the newly forming organism. While competitive ability is regulated by MYC in the epiblast, the mechanisms that contribute to competitive fitness in this context are largely unknown. Here, we report that P53 and its pro-apoptotic targets PUMA and NOXA regulate apoptosis susceptibility and competitive fitness in pluripotent cells. PUMA is widely expressed specifically in pluripotent cells in vitro and in vivo . We found that P53 regulates MYC levels in pluripotent cells, which connects these two Cell competition pathways, however, MYC and PUMA/NOXA levels are independently regulated by P53. We propose a model that integrates a bifurcated P53 pathway regulating both MYC and PUMA/NOXA levels and determines competitive fitness. Cells compete with neighbors for survival in several situations in vitro and in vivo . In mammalian embryos, this phenomenon takes place among pluripotent cells, which are those able to form all the tissues of a new organism. Cell Competition in this context is thought to function as a quality check for the elimination of potentially damaged or dangerous cells (losers) whenever "fitter" cells (winners) are present. Here, we explored the molecular features of winner and loser pluripotent cells and uncovered a pathway that drives the ability of cells to compete. This pathway is governed by p53, a known factor that responds to stress and modulates cell death in several contexts, including cancer. Downstream this pathway, we found that p53 controls Cell Competition by regulating two independent branches; one involving the regulation of MYC, an oncogene previously known to regulate Competition in pluripotent cells, and a second one involving two mitochondrial factors known to regulate cell death and metabolism. Our work uncovers new mechanisms of pluripotent cell competition and show that the p53 cellular stress response pathway is involved in this developmental process.

Cell competition: the winners and losers of fitness selection

Cell competition and the regulation of protein homeostasis

Cell competition: emerging signaling and unsolved questions

Cellular spartans at the pass: Emerging intricacies of cell competition in early and late tumorigenesis

Cell competition and cancer from Drosophila to mammals

To not love thy neighbor: mechanisms of cell competition in stem cells and beyond

Optimal intercellular competition in senescence and cancer

Pleiotropic effects of cell competition between normal and transformed cells in mammalian cancers

Physical traits of supercompetitors in cell competition

Single-cell approaches to cell competition: High-throughput imaging, machine learning and simulations

Mammalian Cell Competitions, Cell-in-Cell Phenomena and Their Biomedical Implications.

P53 and BCL-2 family proteins PUMA and NOXA define competitive fitness in pluripotent cell competition

Mechanisms of Germline Stem Cell Competition across Species

Proteotoxic stress is a driver of the loser status and cell competition

Longitudinal analysis of Flower-dependent cell competition fitness markers in

Extending the Lifespan of Multicellular Organisms via Periodic and Stochastic Intercellular Competition

Flamingo participates in multiple models of cell competition

An ancient defense system eliminates unfit cells from developing tissues during cell competition

Heterotypic competition between cancer cells and hepatocytes generates heterogeneous context-dependent phenotypes

Abstract SY07-03: Cell competition shapes metastatic latency and relapse